Metrics as of 10/16/2026, 04:46 AM (Berlin time), refresh in progress.
LifeStance Health Group Stock
LifeStance Health Group, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- David Patrick Bourdon
- Employees
- 8,542
- Market cap
- $4.5 B
- IPO
- 10/06/2021
LifeStance Health Group, Inc. is a healthcare company specializing in the delivery of outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment as well as specialized psychological and…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
LifeStance Health Group stock: price history
1D
-5.1%
1W
-5.5%
1M
-8.2%
6M
+70.4%
YTD
+66.8%
1Y
+132.9%
2Y
+60.6%
5Y
+2.1%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~159% stronger price swings than usual
LifeStance Health Group stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
LifeStance Health Group, Inc. provides outpatient psychiatric and psychological health services. The offering includes diagnostic evaluations and various forms of therapy for children, adolescents, adults, and seniors. Care is delivered either through an online platform or at physical centers across a total of 32 US states. Treatment areas range from common conditions such as anxiety and depression to more complex disorders including bipolar disorder, eating disorders, and post-traumatic stress disorder.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about LifeStance Health Group
Analyst assessment of LifeStance Health Group
PRICE TARGET LOW
US$9.00
CONSENSUS
US$14.14
MEDIAN
US$15.00
PRICE TARGET HIGH
US$19.00
0
STRONG BUY
9
BUY
2
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 05/10/2026
LifeStance Health Group stock metrics
P/E
90.17
P/B
3.05
EV/EBITDA
33.88
RETURN ON EQUITY
1.6%
NET MARGIN
5.4%
DEBT/EQUITY
0.14
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
52.4%
FLOAT SHARES
200,057,911
AVG. DAILY VOLUME (30D)
4,817,929
Insider transactions (SEC)
Bourdon David
Bourdon David
Bourdon David
Bourdon David
TPG GP A, LLC
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.1%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about LifeStance Health Group stock
What does LifeStance Health Group do?
LifeStance Health Group, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is David Patrick Bourdon, the company employs around 8,542 people.
The IPO was on 10/06/2021; the stock trades on NASDAQ under the ticker LFST.
What do analysts say about LifeStance Health Group stock?
11 analysts rate the stock, the consensus is Buy (as of 05/10/2026).
The average price target is US$14.14, ranging from US$9.00 to US$19.00, with a median of US$15.00.
This is an external assessment, not a statement by Market Jury.
When does LifeStance Health Group report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 159% stronger than usual.
Does LifeStance Health Group pay a dividend?
No, LifeStance Health Group currently does not pay a dividend.
Which stocks are comparable to LifeStance Health Group?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, Concentra Group Holdings Parent, Acadia Healthcare Company and Aveanna Healthcare Holdings.
How can I get LifeStance Health Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess LifeStance Health Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.